TP Therapeutics
TP Therapeutics is a California-based biotechnology company that develops and commercializes medicines for the treatment of cancer.
Business Model:
Revenue: $1M
Employees: 201-500
Rankings
Industries / Tags:
Detailed TP Therapeutics Information
TP Therapeutics was acquired by
Bristol Myers Squibb.
The acquisition happend on 2022-06-03.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 10628 Science Center Drive
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$460M
Raised Total:$311M
Social
Metrics
2,675,643Website Global Rank
6,256Website Monthly Traffic
Twitter Followers
Description
TP Therapeutics is a California-based biotechnology company that develops and commercializes medicines for the treatment of cancer.
Contact Phone:
+18589265251
Contact Email:
TP Therapeutics went public on 4/17/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/17/2019
IPO Valuation:
$534M
Ticker Symbol:
TPTX
IPO Price:
$18/share
Amount Raised:
$167M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2018 | Equity | 9 | $80M |
Lilly Asia Ventures HBM Healthcare Investments AG Foresite Capital Kenson Ventures Cormorant Asset Management venBio Partners Nextech Invest SR One OrbiMed Foresite Capital venBio Partners Lilly Asia Ventures HBM Healthcare Investments AG Foresite Capital Kenson Ventures Cormorant Asset Management venBio Partners Nextech Invest SR One OrbiMed Foresite Capital venBio Partners |
5/2017 | Series C | 5 | $45M |
SR One Lilly Asia Ventures OrbiMed SR One SV Tech Ventures Cormorant Asset Management SR One Lilly Asia Ventures OrbiMed SR One |
4/2019 | IPO | $166.5M |
|
1/2014 | Venture Round | $1.4M | 9/2019 | Post-IPO Equity | $202.5M | 10/2020 | Post-IPO Equity | $460M | 7/2015 | Series B | 1 | - |
CRCM Ventures CRCM Ventures |
5/2020 | Post-IPO Equity | $373.8M | 3/2016 | Series B | 1 | $18M |
CRCM Ventures CRCM Ventures |
12/2013 | Equity | $1.4M | 9/2015 | Series B | $18M | 7/2015 | Series B | 1 | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
